SUSTAINED CORONARY-RISK-FACTOR REDUCTION AFTER GASTRIC BYPASS FOR MORBID-OBESITY

被引:60
作者
GLEYSTEEN, JJ
BARBORIAK, JJ
SASSE, EA
机构
[1] MED COLL WISCONSIN,DEPT SURG,MILWAUKEE,WI 53226
[2] MED COLL WISCONSIN,DEPT PHARMACOL,MILWAUKEE,WI 53226
[3] MED COLL WISCONSIN,DEPT PATHOL,MILWAUKEE,WI 53226
[4] CLEMENT J ZABLOCKI VET ADM MED CTR,MILWAUKEE,WI
关键词
Gastric bypass; Lipids; Lipoproteins; Morbid obesity;
D O I
10.1093/ajcn/51.5.774
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Lipids and clinical changes including diabetes and hypertension were monitored in morbidly obese patients after Roux-Y gastric bypass. Total cholesterol (Chol), high-density-lipoprotein (HDL) cholesterol, and triglycerides at 1 and at 5-7 y postoperatively in 33 patients and at 1 y in 23 patients (including apolipoproteins A-I and B) were compared with preoperative concentrations. Mean concentrations of Chol and both apolipoproteins were unchanged. Elevated serum triglycerides became normal, and reduced concentrations persisted at 5-7 y in men (p < 0.025). HDL-cholesterol concentrations increased at 1 y (p < 0.01) and remained higher at 5-7 y in women. Ratios of Chol to HDL cholesterol were lower at 1 y (p < 0.01) in both men and women. Diabetes (9 patients) and hypertension (22 patients) also were reduced at 1 y (p < 0.01) and remained lower at 5-7 y. A mean 61% of excess weight was lost in 1 y whereas a 12% weight gain occurred by 5-7 y. The beneficial changes in most coronary risk factors lasted 5-7 y after surgery.
引用
收藏
页码:774 / 778
页数:5
相关论文
共 30 条
[1]  
ACKERMAN NB, 1982, SURG GYNECOL OBSTET, V154, P1
[2]  
BARBORIAK JJ, 1979, J LAB CLIN MED, V94, P348
[3]   HDL CHOLESTEROL AND OTHER LIPIDS IN CORONARY HEART-DISEASE - COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY [J].
CASTELLI, WP ;
DOYLE, JT ;
GORDON, T ;
HAMES, CG ;
HJORTLAND, MC ;
HULLEY, SB ;
KAGAN, A ;
ZUKEL, WJ .
CIRCULATION, 1977, 55 (05) :767-772
[4]   SUMMARY ESTIMATES OF CHOLESTEROL USED TO PREDICT CORONARY HEART-DISEASE [J].
CASTELLI, WP ;
ABBOTT, RD ;
MCNAMARA, PM .
CIRCULATION, 1983, 67 (04) :730-734
[5]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[6]   PLASMA HIGH-DENSITY LIPOPROTEIN IN SEVERE OBESITY AFTER STABLE WEIGHT-LOSS [J].
CONTALDO, F ;
STRAZZULLO, P ;
POSTIGLIONE, A ;
RICCARDI, G ;
PATTI, L ;
DIBIASE, G ;
MANCINI, M .
ATHEROSCLEROSIS, 1980, 37 (02) :163-167
[7]   PLASMA-LEVELS OF VLDL-CHOLESTEROL + LDL-CHOLESTEROL, HDL-CHOLESTEROL, TRIGLYCERIDES AND APOPROTEINS-B AND A-I IN A HEALTHY POPULATION - INFLUENCE OF SEVERAL RISK-FACTORS [J].
DEDONDERDECOOPMAN, E ;
FIEVETDESREUMAUX, C ;
CAMPOS, E ;
MOULIN, S ;
DEWAILLY, P ;
SEZILLE, G ;
JAILLARD, J .
ATHEROSCLEROSIS, 1980, 37 (04) :559-568
[8]   EXCESSIVE MORTALITY AND CAUSES OF DEATH IN MORBIDLY OBESE MEN [J].
DRENICK, EJ ;
BALE, GS ;
SELTZER, F ;
JOHNSON, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (05) :443-445
[9]   HIGH-DENSITY LIPOPROTEINS (HDL) AND PHYSICAL-ACTIVITY - INFLUENCE OF PHYSICAL EXERCISE, AGE AND SMOKING ON HDL-CHOLESTEROL AND HDL-1 TOTAL CHOLESTEROL RATIO [J].
ENGER, SC ;
HERBJORNSEN, K ;
ERIKSSEN, J ;
FRETLAND, A .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1977, 37 (03) :251-255
[10]   CIGARETTE-SMOKING AS A CONFOUNDER OF THE RELATIONSHIP BETWEEN RELATIVE WEIGHT AND LONG-TERM MORTALITY - THE FRAMINGHAM HEART-STUDY [J].
GARRISON, RJ ;
FEINLEIB, M ;
CASTELLI, WP ;
MCNAMARA, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (16) :2199-2203